GenBiosis – Genbiosis

Welcome to
GenBiosis Bioresearch

The one-stop solution for all your clinical research need.

Bioavailability

Our team specializes in bioavailability and bioequivalence studies, providing end-to-end support to help pharmaceutical, biotechnology, and generic drug companies optimize formulations and meet regulatory standards.

Clinical Trial

At GenBiosis, our clinical trial team is dedicated to offer comprehensive, high-quality services to support the entire lifecycle of clinical trials.

Medical Writing

Our medical writing team is dedicated to provide high-quality, scientifically accurate and regulatory-compliant study protocols & reports.

Regulatory

Our team has expertise in assessing emerging regulatory trends, developing strategies and defining process improvement that facilitates drug approval & registration process.

GenBiosis Bioresearch is a DCGI approved CRO (Contract Research Organization) based in Pune, India.

GenBiosis Bioresearch is a full-service, independent Contract Research Organization (CRO) founded in 2025, providing clinical research services.

We are offering comprehensive Bioavailability / Bioequivalence (BA/BE) services, Clinical Trial services, Medical Writing services and Regulatory services to global pharmaceutical and biotechnology industry. While leveraging on state-of-the-art facilities, we provide high quality, customized clinical research services with rapid turnaround time and at competitive price. Our customers come from biotechnology and pharmaceuticals sector and spread across geographies like Europe, India and the USA regions. GenBiosis success is supported by its passionate team of experienced professionals backed by deep scientific knowledge and industry experience. We have a world class, compliant facility managed efficiently through our QMS and purpose driven internal SOPs.

Our team plays a crucial role, ensuring that studies are conducted in compliance with the necessary regulatory frameworks and guidelines. This minimizes the risk of delays, ensures participants safety, and provides a clear path to market approval.

Our experienced and GCP trained professionals contribute to the well-being of humanity by delivering quality research services in the process of drug development. With extensive experience in clinical research, we share best practices, expertise, and learnings to enable superior services and results to our sponsors.

Facilities and Infrastructure

GenBiosis has state-of-the-art facilities and infrastructure to facilitate quality execution of studies. The facility is well equipped with Clinical and Bio-analytical setup. We have state-of-the-art equipment, regulatory compliant software, hardware and secured networks. The facility is spread over a total area of 27000 sq. ft. The area covers the clinical units, bioanalytical laboratory area, quality assurance, medical writing area, volunteer screening area, volunteer waiting area, internal archives and offices & cabins.

The clinical unit is equipped with five clinics as follows:

Clinic 01: 34 beds

Clinic 02: 22 beds

Clinic 03: 16 beds

Clinic 04: 60 beds

Clinic 05: 48 beds

Bioanalytical department at GenBiosis is equipped with advanced and fully automated instruments, including 11 LC-MS/MS systems [4500 AB Sciex (08), 6500+ AB Sciex (01), 3200 AB Sciex (02)] coupled with UHPLC/HPLC systems (Agilent), solid-phase extractors, refrigerated centrifuges, nitrogen evaporators, analytical balances, deep freezers (-80 °C), cold storage (-20 °C), refrigerators (2–8 °C), micropipettes and multipipettes. With this comprehensive setup, the department provides complete services in method development, method validation, and routine bioanalysis, ensuring accuracy, reliability, and compliance with international regulatory standards.